Daiichi Sankyo, GSK Plan To Form JV To Develop, Market Vaccines
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and GlaxoSmithKline plan to set up a joint venture for developing and marketing vaccines in a deal yet to be consummated.